Therefore, it may be hypothesized that the decrease in resistin levels in women with PE is due to the smaller size of the placenta, but we could not exclude the possibility of lower expression of resistin by the placenta in preeclampsia, as well as the PE responsibility for an exaggeration of insulin resistance [114]. This evidence concerns the gene RETN and preeclampsia.